Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 23 April 2026
      The escalating burden of non-communicable diseases demands new solutions
 
 
Read the full report here.
 

Managing the status quo is not an option – it is time to change how we fund and deliver health in Europe.

Non-communicable diseases (NCDs) like heart disease, diabetes, obesity and Alzheimer’s, account for 88-90% of all deaths in Europe, and almost one in three people over fifty are living with two or more chronic conditions. They place a heavy cost on European societies in terms of expensive hospital and long-term care, reduced labour force participation, and sickness and disability benefits.

Five major NCDs are estimated to cost EU countries €530 billion annually, which is more than 3% of the EU’s combined annual GDP. And this is not even accounting for the “invisible” burden of informal care, which for Alzheimer’s alone was estimated to over $200 billion for the European region in 2019.

Read more →
 
 
      Blogs
 
  23 April 2026 World IP Day 2026: keeping Europe on track for innovation

As Europe strives to compete globally in life sciences, predictable and robust IP incentives will determine whether...

Read more →
 
 
 
  22 April 2026 The €240 billion leak: Why Europe’s health resilience starts with integrated obesity, diabetes...

Europe is treating the symptoms of a crisis while ignoring the drivers behind it. By the time an EU citizen is diagnosed...

Read more →
 
 
 
      Get ready for IHI Call 13 – launching this summer

The Innovative Health Initiative (IHI) is preparing its next call for proposals, and it brings new opportunities for collaboration across Europe’s health ecosystem. We encourage all interested stakeholders to explore the upcoming topics and start building strong consortia ahead of the official launch in the Summer.

What’s coming in Call 13?

  • IHI European HealthCare Incubator Network
  • New Approach Methodologies (NAMs)
  • Ageing & immune system

Learn more here.

 
 
 
      Events
 
 
07 MAY 2026
  Towards comprehensive cardiovascular health checks across Europe Brussels, Belgium

Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity in Europe, despite significant advances...

Learn more →
 
 
 
19 MAY 2026
  European Pharmaceutical Law Forum Brussels, Belgium

The European pharmaceutical market is facing a moment of profound change. With sweeping updates to the EU pharmaceutical...

Learn more →
 
 
      What we are reading
International 3Rs Prize 22 April 2026  (NC3Rs) Read more →
Health Checks for Cardiovascular diseases 21 April 2026  (European Commission) Read more →
#AlwaysInnovating: There’s more to medicines and vaccines 21 April 2026  (IFPMA) Read more →
Health, ​r​​​esilience and ​prosperity: Why ​immunization ​matters 20 April 2026  (POLITICO) Read more →
Healthcare needs judgement, not just metrics 08 April 2026  (University of St Andrews) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe